MINNEAPOLIS, May 8, 2024
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today
announced that Kim Kelderman,
President and Chief Executive Officer, will present at the BofA
Securities Health Care Conference on Tuesday, May 14, 2024, at 2:20 p.m. PDT. A live webcast of the presentation
can be accessed via the IR Calendar page of Bio-Techne's Investor
Relations website at
https://investors.bio-techne.com/ir-calendar.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH)
is a global life sciences company providing innovative tools and
bioactive reagents for the research and clinical diagnostic
communities. Bio-Techne products assist scientific investigations
into biological processes and the nature and progress of specific
diseases. They aid in drug discovery efforts and provide the means
for accurate clinical tests and diagnoses. With thousands of
products in its portfolio, Bio-Techne generated over $1.1 billion in net sales in fiscal 2023 and has
approximately 3,100 employees worldwide. For more information on
Bio-Techne and its brands, please visit http://www.bio-techne.com
or follow the Company on social media at Facebook, LinkedIn,
Twitter or YouTube.
About Bio-Techne Corporation (NASDAQ: TECH)
Contact: David Clair, Vice
President, Investor Relations & Corporate Development
david.clair@bio-techne.com
612-656-4416
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-bofa-securities-health-care-conference-2024-302139323.html
SOURCE Bio-Techne Corporation